Rank | Gene Set | Z-score |
---|---|---|
1 | cellular response to ethanol (GO:0071361) | 9.12604257 |
2 | response to hydroperoxide (GO:0033194) | 7.98804162 |
3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.71064145 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.66352604 |
5 | negative regulation of thymocyte apoptotic process (GO:0070244) | 6.53180599 |
6 | resolution of meiotic recombination intermediates (GO:0000712) | 6.43915361 |
7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.28442618 |
8 | cellular hyperosmotic response (GO:0071474) | 6.12654848 |
9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.11249664 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.11249664 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 5.91542201 |
12 | ribosomal small subunit assembly (GO:0000028) | 5.81673335 |
13 | somatic cell DNA recombination (GO:0016444) | 5.80346455 |
14 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 5.80346455 |
15 | purine nucleotide salvage (GO:0032261) | 5.68255171 |
16 | histone monoubiquitination (GO:0010390) | 5.61711002 |
17 | B cell differentiation (GO:0030183) | 5.57496237 |
18 | DNA unwinding involved in DNA replication (GO:0006268) | 5.41000693 |
19 | somatic diversification of immune receptors (GO:0002200) | 5.39377063 |
20 | positive T cell selection (GO:0043368) | 5.18512194 |
21 | mucosal-associated lymphoid tissue development (GO:0048537) | 5.01815024 |
22 | Peyers patch development (GO:0048541) | 5.01815024 |
23 | establishment of integrated proviral latency (GO:0075713) | 4.99049494 |
24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.95815602 |
25 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.94662140 |
26 | negative regulation of B cell apoptotic process (GO:0002903) | 4.86114638 |
27 | regulation of T cell apoptotic process (GO:0070232) | 4.84418540 |
28 | purine ribonucleotide transport (GO:0015868) | 4.82258075 |
29 | B cell proliferation (GO:0042100) | 4.64531678 |
30 | T cell differentiation in thymus (GO:0033077) | 4.61737900 |
31 | positive regulation of B cell differentiation (GO:0045579) | 4.59377132 |
32 | negative T cell selection (GO:0043383) | 4.53116013 |
33 | adenine nucleotide transport (GO:0051503) | 4.50611031 |
34 | DNA ligation (GO:0006266) | 4.42554981 |
35 | viral transcription (GO:0019083) | 4.42483883 |
36 | mast cell activation (GO:0045576) | 4.40846923 |
37 | interleukin-6-mediated signaling pathway (GO:0070102) | 4.37524238 |
38 | translational termination (GO:0006415) | 4.18799757 |
39 | T cell homeostasis (GO:0043029) | 4.17359210 |
40 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.13882959 |
41 | regulation of thymocyte apoptotic process (GO:0070243) | 4.11626637 |
42 | mast cell activation involved in immune response (GO:0002279) | 4.10868002 |
43 | mast cell degranulation (GO:0043303) | 4.10868002 |
44 | nucleotide salvage (GO:0043173) | 4.09362883 |
45 | negative regulation of leukocyte apoptotic process (GO:2000107) | 4.02363509 |
46 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.01949013 |
47 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.01949013 |
48 | T cell selection (GO:0045058) | 4.00431083 |
49 | establishment of viral latency (GO:0019043) | 3.99557410 |
50 | negative regulation of sodium ion transport (GO:0010766) | 3.99109461 |
51 | histone ubiquitination (GO:0016574) | 3.98978410 |
52 | T cell differentiation (GO:0030217) | 3.97606101 |
53 | T cell receptor signaling pathway (GO:0050852) | 3.97458269 |
54 | B cell activation (GO:0042113) | 3.95980779 |
55 | heparin metabolic process (GO:0030202) | 3.95856110 |
56 | heparin biosynthetic process (GO:0030210) | 3.95856110 |
57 | negative regulation of cell aging (GO:0090344) | 3.95632401 |
58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.88939793 |
59 | negative regulation of T cell apoptotic process (GO:0070233) | 3.87886244 |
60 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.87787458 |
61 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.87442176 |
62 | regulation of B cell differentiation (GO:0045577) | 3.82908072 |
63 | regulation of chromatin silencing (GO:0031935) | 3.81184529 |
64 | purine-containing compound salvage (GO:0043101) | 3.79841539 |
65 | DNA strand elongation (GO:0022616) | 3.79460704 |
66 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.72417091 |
67 | activated T cell proliferation (GO:0050798) | 3.71311789 |
68 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.70854184 |
69 | regulation of lymphocyte apoptotic process (GO:0070228) | 3.70034265 |
70 | translational elongation (GO:0006414) | 3.67533666 |
71 | positive regulation of granulocyte differentiation (GO:0030854) | 3.67062797 |
72 | regulation of histone H3-K9 methylation (GO:0051570) | 3.67035930 |
73 | labyrinthine layer development (GO:0060711) | 3.66395776 |
74 | positive thymic T cell selection (GO:0045059) | 3.66045809 |
75 | T cell lineage commitment (GO:0002360) | 3.64869876 |
76 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.63246606 |
77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.61803932 |
78 | purine nucleotide transport (GO:0015865) | 3.61408995 |
79 | response to vitamin E (GO:0033197) | 3.57572668 |
80 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.56249879 |
81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.56249879 |
82 | regulation of germinal center formation (GO:0002634) | 3.55838608 |
83 | regulation of circadian sleep/wake cycle (GO:0042749) | 3.53816375 |
84 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 3.53816375 |
85 | positive regulation by host of viral transcription (GO:0043923) | 3.52023502 |
86 | regulation of translation in response to stress (GO:0043555) | 3.51013876 |
87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.50338158 |
88 | nucleosome disassembly (GO:0006337) | 3.49562025 |
89 | protein-DNA complex disassembly (GO:0032986) | 3.49562025 |
90 | mitotic chromosome condensation (GO:0007076) | 3.48660832 |
91 | regulation of response to tumor cell (GO:0002834) | 3.47414575 |
92 | positive regulation of response to tumor cell (GO:0002836) | 3.47414575 |
93 | positive regulation of immune response to tumor cell (GO:0002839) | 3.47414575 |
94 | regulation of immune response to tumor cell (GO:0002837) | 3.47414575 |
95 | dosage compensation (GO:0007549) | 3.47312915 |
96 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.44435107 |
97 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.43260092 |
98 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.40735647 |
99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.38046118 |
100 | ribosomal small subunit biogenesis (GO:0042274) | 3.37678545 |
101 | hepatocyte differentiation (GO:0070365) | 3.37402477 |
102 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.36750875 |
103 | cotranslational protein targeting to membrane (GO:0006613) | 3.35538539 |
104 | genitalia morphogenesis (GO:0035112) | 3.34311368 |
105 | protein targeting to ER (GO:0045047) | 3.33626282 |
106 | immunoglobulin mediated immune response (GO:0016064) | 3.33329728 |
107 | regulation of antigen processing and presentation (GO:0002577) | 3.32623187 |
108 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.31570322 |
109 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.31367910 |
110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.30664869 |
111 | lymphocyte homeostasis (GO:0002260) | 3.30625423 |
112 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.28809680 |
113 | leukocyte homeostasis (GO:0001776) | 3.26855633 |
114 | cellular protein complex disassembly (GO:0043624) | 3.26828600 |
115 | B cell receptor signaling pathway (GO:0050853) | 3.26029871 |
116 | protein complex disassembly (GO:0043241) | 3.23943349 |
117 | translesion synthesis (GO:0019985) | 3.23102883 |
118 | replicative senescence (GO:0090399) | 3.22340618 |
119 | lymphoid progenitor cell differentiation (GO:0002320) | 3.21057424 |
120 | regulation of B cell apoptotic process (GO:0002902) | 3.20913472 |
121 | positive regulation of antigen processing and presentation (GO:0002579) | 3.19998707 |
122 | alpha-beta T cell differentiation (GO:0046632) | 3.19992343 |
123 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.17723992 |
124 | DNA topological change (GO:0006265) | 3.17373680 |
125 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17124440 |
126 | viral life cycle (GO:0019058) | 3.17023421 |
127 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.16780538 |
128 | DNA replication initiation (GO:0006270) | 3.16767097 |
129 | response to histamine (GO:0034776) | 3.15029561 |
130 | G-protein coupled receptor internalization (GO:0002031) | 3.14830197 |
131 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.14460589 |
132 | negative regulation of RNA splicing (GO:0033119) | 3.12332299 |
133 | cellular response to interleukin-4 (GO:0071353) | 3.11215653 |
134 | alpha-beta T cell activation (GO:0046631) | 3.10390865 |
135 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.10298078 |
136 | thymus development (GO:0048538) | 3.10164408 |
137 | protein localization to endoplasmic reticulum (GO:0070972) | 3.09793396 |
138 | interferon-gamma production (GO:0032609) | 3.09146932 |
139 | maturation of SSU-rRNA (GO:0030490) | 3.08719586 |
140 | regulation of proton transport (GO:0010155) | 3.07833374 |
141 | musculoskeletal movement (GO:0050881) | 3.07487922 |
142 | multicellular organismal movement (GO:0050879) | 3.07487922 |
143 | positive regulation of organ growth (GO:0046622) | 3.06106963 |
144 | positive regulation of renal sodium excretion (GO:0035815) | 3.04436400 |
145 | natural killer cell differentiation (GO:0001779) | 3.02623256 |
146 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.02424833 |
147 | ether lipid metabolic process (GO:0046485) | 3.02177027 |
148 | prepulse inhibition (GO:0060134) | 3.01862553 |
149 | mitotic sister chromatid cohesion (GO:0007064) | 3.00957178 |
150 | negative regulation of gene expression, epigenetic (GO:0045814) | 3.00535974 |
151 | mitotic recombination (GO:0006312) | 3.00118372 |
152 | lymphocyte differentiation (GO:0030098) | 2.98994176 |
153 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.98675965 |
154 | macromolecular complex disassembly (GO:0032984) | 2.96840022 |
155 | lymphocyte proliferation (GO:0046651) | 2.96665583 |
156 | T cell costimulation (GO:0031295) | 2.93684707 |
157 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.92481062 |
158 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.91368386 |
159 | T cell activation (GO:0042110) | 2.88692911 |
160 | translational initiation (GO:0006413) | 2.88455901 |
161 | mononuclear cell proliferation (GO:0032943) | 2.85574634 |
162 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.84555505 |
163 | icosanoid secretion (GO:0032309) | 2.84367363 |
164 | arachidonic acid secretion (GO:0050482) | 2.84367363 |
165 | deoxyribose phosphate catabolic process (GO:0046386) | 2.84060875 |
166 | deoxyribonucleotide catabolic process (GO:0009264) | 2.83259755 |
167 | lipopolysaccharide metabolic process (GO:0008653) | 2.82910782 |
168 | pyrimidine-containing compound salvage (GO:0008655) | 2.82381577 |
169 | pyrimidine nucleoside salvage (GO:0043097) | 2.82381577 |
170 | regulation of neurotransmitter uptake (GO:0051580) | 2.82148333 |
171 | response to pheromone (GO:0019236) | 2.82117140 |
172 | protein autoubiquitination (GO:0051865) | 2.79132408 |
173 | V(D)J recombination (GO:0033151) | 11.0003839 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.96596904 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.80458562 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 3.75739946 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.69092004 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.68111928 |
6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.43726397 |
7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.26197363 |
8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.20538516 |
9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.08783121 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03120854 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.75508324 |
12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.71423346 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64107290 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.53788307 |
15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.47343674 |
16 | EWS_26573619_Chip-Seq_HEK293_Human | 2.45899282 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43933423 |
18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.28220792 |
19 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.24956205 |
20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.20755693 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20051287 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.15772437 |
23 | MAF_26560356_Chip-Seq_TH1_Human | 2.08601945 |
24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05731824 |
25 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04708108 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01375196 |
27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.3072962 |
28 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99654833 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99371847 |
30 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97642805 |
31 | MYB_26560356_Chip-Seq_TH1_Human | 1.90837741 |
32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.88450880 |
33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86067585 |
34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.83289980 |
35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78765624 |
36 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.75958382 |
37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71322743 |
38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.69144840 |
39 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.67536690 |
40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65711615 |
41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64011391 |
42 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63997393 |
43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62625513 |
44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61339755 |
45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61077751 |
46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60498131 |
47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56932641 |
48 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56911843 |
49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56034426 |
50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55106661 |
51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54492647 |
52 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.54068418 |
53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53760393 |
54 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.53734821 |
55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53671488 |
56 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.52951097 |
57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.52912695 |
58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51840855 |
59 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51449251 |
60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43218648 |
61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38998484 |
62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38449808 |
63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38214419 |
64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.37624035 |
65 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35669880 |
66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35262556 |
67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34810684 |
68 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.34196545 |
69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33744770 |
70 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.30488911 |
71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28157620 |
72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27268396 |
73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.26939774 |
74 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.26924884 |
75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24473696 |
76 | MAF_26560356_Chip-Seq_TH2_Human | 1.24156355 |
77 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21647773 |
78 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20104550 |
79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20069394 |
80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19969639 |
81 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18755509 |
82 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.18290125 |
83 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.17798482 |
84 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.17238429 |
85 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16618839 |
86 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16343102 |
87 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16163306 |
88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14596128 |
89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14582228 |
90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14557110 |
91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12825951 |
92 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12217414 |
93 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11707463 |
94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10855994 |
95 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09610768 |
96 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.08454639 |
97 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06829875 |
98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.04012961 |
99 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01568596 |
100 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.01530910 |
101 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99498245 |
102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99018985 |
103 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.96802599 |
104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96030998 |
105 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.94476601 |
106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94140880 |
107 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93916284 |
108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93015340 |
109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93015333 |
110 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.92529357 |
111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91939639 |
112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89464977 |
113 | * P300_27268052_Chip-Seq_Bcells_Human | 0.89065373 |
114 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88917276 |
115 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.88849130 |
116 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88234013 |
117 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.88058539 |
118 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.86514475 |
119 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.86111820 |
120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85329215 |
121 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.84793176 |
122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.83989415 |
123 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83842609 |
124 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.82575782 |
125 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82499316 |
126 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81820122 |
127 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.81571963 |
128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81514414 |
129 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81508505 |
130 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.80393088 |
131 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.80272204 |
132 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78716091 |
133 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.78384263 |
134 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.78247844 |
135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77545903 |
136 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.76528444 |
137 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.75981768 |
138 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75660961 |
139 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.75462706 |
140 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75258261 |
141 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75203247 |
142 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.75017061 |
143 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.75017061 |
144 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.74714345 |
145 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.74566934 |
146 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73987424 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005451_abnormal_body_composition | 4.88471145 |
2 | MP0003763_abnormal_thymus_physiology | 4.12638749 |
3 | MP0002396_abnormal_hematopoietic_system | 3.87774666 |
4 | MP0009278_abnormal_bone_marrow | 3.68421435 |
5 | MP0002166_altered_tumor_susceptibility | 3.62655230 |
6 | MP0005409_darkened_coat_color | 3.43554454 |
7 | MP0010094_abnormal_chromosome_stability | 3.42973750 |
8 | MP0000703_abnormal_thymus_morphology | 3.41105436 |
9 | MP0005671_abnormal_response_to | 3.28006636 |
10 | MP0001835_abnormal_antigen_presentation | 2.98738134 |
11 | MP0001545_abnormal_hematopoietic_system | 2.89059893 |
12 | MP0005397_hematopoietic_system_phenotyp | 2.89059893 |
13 | MP0002006_tumorigenesis | 2.81575724 |
14 | MP0004808_abnormal_hematopoietic_stem | 2.76289749 |
15 | * MP0002398_abnormal_bone_marrow | 2.66884678 |
16 | MP0009785_altered_susceptibility_to | 2.65363930 |
17 | MP0008007_abnormal_cellular_replicative | 2.59981029 |
18 | MP0002722_abnormal_immune_system | 2.37532717 |
19 | MP0000689_abnormal_spleen_morphology | 2.25195211 |
20 | MP0001800_abnormal_humoral_immune | 2.24126171 |
21 | MP0004947_skin_inflammation | 2.24017429 |
22 | * MP0000716_abnormal_immune_system | 2.15679653 |
23 | MP0004084_abnormal_cardiac_muscle | 2.13621420 |
24 | MP0010155_abnormal_intestine_physiology | 2.11069288 |
25 | * MP0000685_abnormal_immune_system | 2.05997982 |
26 | MP0002420_abnormal_adaptive_immunity | 2.04707304 |
27 | MP0001819_abnormal_immune_cell | 2.00697095 |
28 | MP0005174_abnormal_tail_pigmentation | 1.97447027 |
29 | MP0002723_abnormal_immune_serum | 1.95422957 |
30 | MP0002132_abnormal_respiratory_system | 1.90974841 |
31 | MP0009333_abnormal_splenocyte_physiolog | 1.88516951 |
32 | MP0002095_abnormal_skin_pigmentation | 1.87201703 |
33 | MP0000490_abnormal_crypts_of | 1.86187071 |
34 | MP0003693_abnormal_embryo_hatching | 1.85332559 |
35 | * MP0002429_abnormal_blood_cell | 1.85238285 |
36 | MP0002405_respiratory_system_inflammati | 1.81726012 |
37 | MP0005025_abnormal_response_to | 1.79105297 |
38 | MP0002452_abnormal_antigen_presenting | 1.77070911 |
39 | MP0001790_abnormal_immune_system | 1.68072750 |
40 | MP0005387_immune_system_phenotype | 1.68072750 |
41 | MP0003077_abnormal_cell_cycle | 1.59001406 |
42 | * MP0005000_abnormal_immune_tolerance | 1.58198913 |
43 | MP0002019_abnormal_tumor_incidence | 1.55364167 |
44 | MP0001853_heart_inflammation | 1.54192986 |
45 | MP0002148_abnormal_hypersensitivity_rea | 1.53515679 |
46 | MP0009697_abnormal_copulation | 1.53214514 |
47 | MP0005464_abnormal_platelet_physiology | 1.51912677 |
48 | MP0003283_abnormal_digestive_organ | 1.51803324 |
49 | MP0000015_abnormal_ear_pigmentation | 1.50595574 |
50 | MP0008057_abnormal_DNA_replication | 1.48174010 |
51 | MP0004957_abnormal_blastocyst_morpholog | 1.45638384 |
52 | MP0005075_abnormal_melanosome_morpholog | 1.45244807 |
53 | MP0002138_abnormal_hepatobiliary_system | 1.43540480 |
54 | MP0010352_gastrointestinal_tract_polyps | 1.42788410 |
55 | MP0001849_ear_inflammation | 1.42382416 |
56 | MP0003111_abnormal_nucleus_morphology | 1.41836400 |
57 | MP0003300_gastrointestinal_ulcer | 1.38165658 |
58 | MP0002876_abnormal_thyroid_physiology | 1.33568278 |
59 | MP0008058_abnormal_DNA_repair | 1.33496427 |
60 | MP0002419_abnormal_innate_immunity | 1.27584287 |
61 | MP0004381_abnormal_hair_follicle | 1.23142374 |
62 | MP0006054_spinal_hemorrhage | 1.20227248 |
63 | MP0000465_gastrointestinal_hemorrhage | 1.18948902 |
64 | MP0003866_abnormal_defecation | 1.15185615 |
65 | MP0001845_abnormal_inflammatory_respons | 1.11210392 |
66 | MP0003252_abnormal_bile_duct | 1.07377314 |
67 | MP0008872_abnormal_physiological_respon | 1.06600467 |
68 | MP0001873_stomach_inflammation | 1.05621605 |
69 | MP0002933_joint_inflammation | 1.05134281 |
70 | MP0002075_abnormal_coat/hair_pigmentati | 1.04018194 |
71 | MP0000350_abnormal_cell_proliferation | 1.03861610 |
72 | MP0001905_abnormal_dopamine_level | 1.03020626 |
73 | MP0003436_decreased_susceptibility_to | 0.94650418 |
74 | MP0008877_abnormal_DNA_methylation | 0.91847906 |
75 | MP0004036_abnormal_muscle_relaxation | 0.91745773 |
76 | MP0008775_abnormal_heart_ventricle | 0.91705228 |
77 | MP0000383_abnormal_hair_follicle | 0.90562604 |
78 | MP0003724_increased_susceptibility_to | 0.89088223 |
79 | MP0005365_abnormal_bile_salt | 0.88509969 |
80 | MP0000013_abnormal_adipose_tissue | 0.88128301 |
81 | MP0002127_abnormal_cardiovascular_syste | 0.85964838 |
82 | MP0001879_abnormal_lymphatic_vessel | 0.85575647 |
83 | MP0000470_abnormal_stomach_morphology | 0.82165844 |
84 | MP0008469_abnormal_protein_level | 0.81451857 |
85 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79681224 |
86 | MP0010307_abnormal_tumor_latency | 0.78654303 |
87 | MP0001243_abnormal_dermal_layer | 0.78423995 |
88 | MP0000858_altered_metastatic_potential | 0.77328915 |
89 | MP0000313_abnormal_cell_death | 0.76534365 |
90 | MP0002009_preneoplasia | 0.75843368 |
91 | MP0005220_abnormal_exocrine_pancreas | 0.74991289 |
92 | MP0000462_abnormal_digestive_system | 0.74964462 |
93 | MP0002998_abnormal_bone_remodeling | 0.73665308 |
94 | MP0006082_CNS_inflammation | 0.72857161 |
95 | MP0006072_abnormal_retinal_apoptosis | 0.72079388 |
96 | MP0004130_abnormal_muscle_cell | 0.68233436 |
97 | MP0000477_abnormal_intestine_morphology | 0.66618038 |
98 | MP0001186_pigmentation_phenotype | 0.65204617 |
99 | MP0000609_abnormal_liver_physiology | 0.64158665 |
100 | MP0002970_abnormal_white_adipose | 0.63763331 |
101 | MP0008770_decreased_survivor_rate | 0.63319096 |
102 | MP0001730_embryonic_growth_arrest | 0.62042818 |
103 | MP0001542_abnormal_bone_strength | 0.62015320 |
104 | MP0003868_abnormal_feces_composition | 0.61742055 |
105 | MP0010678_abnormal_skin_adnexa | 0.61071620 |
106 | MP0009765_abnormal_xenobiotic_induced | 0.58832843 |
107 | MP0001177_atelectasis | 0.58538947 |
108 | MP0000377_abnormal_hair_follicle | 0.58101523 |
109 | MP0002083_premature_death | 0.55461734 |
110 | MP0000367_abnormal_coat/_hair | 0.55274397 |
111 | MP0003959_abnormal_lean_body | 0.54884974 |
112 | MP0008873_increased_physiological_sensi | 0.53988085 |
113 | MP0003943_abnormal_hepatobiliary_system | 0.53039377 |
114 | MP0002060_abnormal_skin_morphology | 0.51834824 |
115 | MP0001944_abnormal_pancreas_morphology | 0.50431917 |
116 | MP0002080_prenatal_lethality | 0.49140245 |
117 | MP0005381_digestive/alimentary_phenotyp | 0.48696421 |
118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48406260 |
119 | MP0001663_abnormal_digestive_system | 0.48226256 |
120 | MP0004043_abnormal_pH_regulation | 0.48069314 |
121 | MP0009931_abnormal_skin_appearance | 0.47863244 |
122 | MP0003828_pulmonary_edema | 0.47240693 |
123 | MP0001191_abnormal_skin_condition | 0.45335803 |
124 | MP0006292_abnormal_olfactory_placode | 0.44857705 |
125 | MP0009764_decreased_sensitivity_to | 0.44692925 |
126 | MP0000249_abnormal_blood_vessel | 0.43685442 |
127 | MP0005645_abnormal_hypothalamus_physiol | 0.43556163 |
128 | MP0002653_abnormal_ependyma_morphology | 0.42904492 |
129 | MP0005360_urolithiasis | 0.40157943 |
130 | MP0001529_abnormal_vocalization | 0.39385143 |
131 | MP0002160_abnormal_reproductive_system | 0.39206231 |
132 | MP0001216_abnormal_epidermal_layer | 0.37760161 |
133 | MP0006138_congestive_heart_failure | 0.36946171 |
134 | MP0003183_abnormal_peptide_metabolism | 0.35748250 |
135 | MP0005084_abnormal_gallbladder_morpholo | 0.33418563 |
136 | MP0004133_heterotaxia | 0.31527641 |
137 | MP0003795_abnormal_bone_structure | 0.29616516 |
138 | MP0001440_abnormal_grooming_behavior | 0.29442049 |
139 | MP0005389_reproductive_system_phenotype | 0.27816645 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of B cell number (HP:0010975) | 9.96376804 |
2 | B lymphocytopenia (HP:0010976) | 9.96376804 |
3 | Hypoplasia of the thymus (HP:0000778) | 8.73105741 |
4 | Thyroiditis (HP:0100646) | 8.59568453 |
5 | T lymphocytopenia (HP:0005403) | 8.48531262 |
6 | Severe combined immunodeficiency (HP:0004430) | 7.97986144 |
7 | Panhypogammaglobulinemia (HP:0003139) | 7.95052862 |
8 | Abnormality of T cell number (HP:0011839) | 7.94911646 |
9 | Combined immunodeficiency (HP:0005387) | 6.88819873 |
10 | Eosinophilia (HP:0001880) | 6.38088240 |
11 | Recurrent viral infections (HP:0004429) | 6.26486501 |
12 | Hypoproteinemia (HP:0003075) | 6.14501122 |
13 | Granulocytopenia (HP:0001913) | 5.39286658 |
14 | Abnormality of eosinophils (HP:0001879) | 4.80586838 |
15 | Abnormality of T cells (HP:0002843) | 4.77098870 |
16 | IgG deficiency (HP:0004315) | 4.71091738 |
17 | Recurrent fungal infections (HP:0002841) | 4.13877350 |
18 | Acute lymphatic leukemia (HP:0006721) | 4.12849895 |
19 | Chronic otitis media (HP:0000389) | 3.95273987 |
20 | Erythroderma (HP:0001019) | 3.77137263 |
21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49670999 |
22 | Leukocytosis (HP:0001974) | 3.37770672 |
23 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 3.33366481 |
24 | Meningitis (HP:0001287) | 3.28941214 |
25 | Papilloma (HP:0012740) | 3.03868970 |
26 | Verrucae (HP:0200043) | 3.03868970 |
27 | Recurrent bronchitis (HP:0002837) | 3.01515690 |
28 | Agammaglobulinemia (HP:0004432) | 2.95473598 |
29 | Reticulocytopenia (HP:0001896) | 2.89868135 |
30 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.88483601 |
31 | Abnormality of the fingertips (HP:0001211) | 2.78718095 |
32 | Abnormality of the thymus (HP:0000777) | 2.78017923 |
33 | Abnormal number of erythroid precursors (HP:0012131) | 2.71733366 |
34 | Lymphoma (HP:0002665) | 2.66183466 |
35 | IgM deficiency (HP:0002850) | 2.58411166 |
36 | Sepsis (HP:0100806) | 2.50476097 |
37 | Cellulitis (HP:0100658) | 2.49211530 |
38 | Recurrent pneumonia (HP:0006532) | 2.42396894 |
39 | Nasal polyposis (HP:0100582) | 2.42327311 |
40 | Acute myeloid leukemia (HP:0004808) | 2.39042155 |
41 | Thrombocytosis (HP:0001894) | 2.38942217 |
42 | Autoimmune hemolytic anemia (HP:0001890) | 2.37791662 |
43 | Chronic sinusitis (HP:0011109) | 2.23783937 |
44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15311172 |
45 | Poikiloderma (HP:0001029) | 2.13319512 |
46 | Abnormality of the nasal mucosa (HP:0000433) | 2.06376378 |
47 | Aplastic anemia (HP:0001915) | 2.01619284 |
48 | Cutaneous melanoma (HP:0012056) | 2.00203487 |
49 | Cutis marmorata (HP:0000965) | 1.99343242 |
50 | Myositis (HP:0100614) | 1.96840769 |
51 | Bicuspid aortic valve (HP:0001647) | 1.92582126 |
52 | Abnormality of T cell physiology (HP:0011840) | 1.91603243 |
53 | Muscle fiber atrophy (HP:0100295) | 1.91388205 |
54 | Entropion (HP:0000621) | 1.90171386 |
55 | Type 2 muscle fiber atrophy (HP:0003554) | 1.88831664 |
56 | Macrocytic anemia (HP:0001972) | 1.86664309 |
57 | Cellular immunodeficiency (HP:0005374) | 1.82839660 |
58 | Lymphopenia (HP:0001888) | 1.80725544 |
59 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.80708799 |
60 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80462558 |
61 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80462558 |
62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.78649544 |
63 | Hyperacusis (HP:0010780) | 1.77037044 |
64 | Volvulus (HP:0002580) | 1.75779670 |
65 | Gastrointestinal inflammation (HP:0004386) | 1.71624213 |
66 | Basal cell carcinoma (HP:0002671) | 1.69983743 |
67 | Pruritus (HP:0000989) | 1.69970280 |
68 | Recurrent lower respiratory tract infections (HP:0002783) | 1.68964676 |
69 | Colitis (HP:0002583) | 1.65144976 |
70 | Nephrotic syndrome (HP:0000100) | 1.64851657 |
71 | Bronchitis (HP:0012387) | 1.64511565 |
72 | Osteomyelitis (HP:0002754) | 1.61547867 |
73 | Inflammation of the large intestine (HP:0002037) | 1.59785808 |
74 | Autoimmune thrombocytopenia (HP:0001973) | 1.58508501 |
75 | Pallor (HP:0000980) | 1.54833828 |
76 | Long eyelashes (HP:0000527) | 1.51465699 |
77 | Colon cancer (HP:0003003) | 1.49999977 |
78 | Abnormality of the intervertebral disk (HP:0005108) | 1.48771791 |
79 | Amaurosis fugax (HP:0100576) | 1.45823148 |
80 | Increased nuchal translucency (HP:0010880) | 1.45537060 |
81 | Prolonged bleeding time (HP:0003010) | 1.43422974 |
82 | Encephalitis (HP:0002383) | 1.43150108 |
83 | Spontaneous hematomas (HP:0007420) | 1.40584083 |
84 | Recurrent abscess formation (HP:0002722) | 1.35393611 |
85 | Pancytopenia (HP:0001876) | 1.34555223 |
86 | Recurrent skin infections (HP:0001581) | 1.32808417 |
87 | Dehydration (HP:0001944) | 1.32741279 |
88 | Chronic diarrhea (HP:0002028) | 1.32042643 |
89 | Squamous cell carcinoma (HP:0002860) | 1.31675071 |
90 | Skin rash (HP:0000988) | 1.30819218 |
91 | Myelodysplasia (HP:0002863) | 1.29716438 |
92 | Interstitial pulmonary disease (HP:0006530) | 1.27870096 |
93 | Prostate neoplasm (HP:0100787) | 1.26486434 |
94 | Pustule (HP:0200039) | 1.24881992 |
95 | Broad alveolar ridges (HP:0000187) | 1.22458872 |
96 | Broad palm (HP:0001169) | 1.22369419 |
97 | Deep philtrum (HP:0002002) | 1.20353281 |
98 | Recurrent bacterial skin infections (HP:0005406) | 1.19475738 |
99 | Overlapping toe (HP:0001845) | 1.18946259 |
100 | Abnormality of DNA repair (HP:0003254) | 1.18362545 |
101 | 11 pairs of ribs (HP:0000878) | 1.18251302 |
102 | Skin ulcer (HP:0200042) | 1.17669750 |
103 | Stomach cancer (HP:0012126) | 1.16554306 |
104 | Abnormality of oral frenula (HP:0000190) | 1.16364876 |
105 | Mesangial abnormality (HP:0001966) | 1.16184575 |
106 | Neutropenia (HP:0001875) | 1.15913712 |
107 | Recurrent otitis media (HP:0000403) | 1.15592194 |
108 | Hypoplasia of the pons (HP:0012110) | 1.15582599 |
109 | Bronchiectasis (HP:0002110) | 1.15433293 |
110 | Abnormality of the columella (HP:0009929) | 1.15399407 |
111 | Abnormality of the pons (HP:0007361) | 1.11146257 |
112 | Abnormality of the prostate (HP:0008775) | 1.10926099 |
113 | Visual hallucinations (HP:0002367) | 1.10512482 |
114 | Increased IgE level (HP:0003212) | 1.08784287 |
115 | Constricted visual fields (HP:0001133) | 1.06815791 |
116 | Nonimmune hydrops fetalis (HP:0001790) | 1.00325397 |
117 | Dry skin (HP:0000958) | 0.99628663 |
118 | Hypothyroidism (HP:0000821) | 0.97999951 |
119 | Abnormal pancreas size (HP:0012094) | 0.93426425 |
120 | Methylmalonic acidemia (HP:0002912) | 0.92644024 |
121 | Carpal bone hypoplasia (HP:0001498) | 0.90952491 |
122 | Multiple enchondromatosis (HP:0005701) | 0.89365562 |
123 | Acute hepatic failure (HP:0006554) | 0.88468441 |
124 | Polygenic inheritance (HP:0010982) | 0.87798374 |
125 | External ear malformation (HP:0008572) | 0.87715237 |
126 | Type I transferrin isoform profile (HP:0003642) | 0.87236723 |
127 | Small epiphyses (HP:0010585) | 0.86316779 |
128 | Cupped ribs (HP:0000887) | 0.86174440 |
129 | Abnormal rod and cone electroretinograms (HP:0008323) | 0.81661328 |
130 | Abnormal foot bone ossification (HP:0010675) | 0.80697401 |
131 | Chronic hepatic failure (HP:0100626) | 0.79954399 |
132 | Abnormality of endocrine pancreas physiology (HP:0012093) | 0.79439293 |
133 | Abnormality of the pancreatic islet cells (HP:0006476) | 0.79439293 |
134 | Abnormal tarsal ossification (HP:0008369) | 0.76663492 |
135 | Barrel-shaped chest (HP:0001552) | 0.74863779 |
136 | Attenuation of retinal blood vessels (HP:0007843) | 0.72710289 |
137 | Lower limb hyperreflexia (HP:0002395) | 0.71813055 |
138 | Hypokalemic alkalosis (HP:0001949) | 0.71145898 |
139 | Abnormality of the fingernails (HP:0001231) | 0.70203701 |
140 | Hematochezia (HP:0002573) | 0.70010544 |
141 | Methylmalonic aciduria (HP:0012120) | 0.68538714 |
142 | Infantile onset (HP:0003593) | 0.64985937 |
143 | Abnormality of male internal genitalia (HP:0000022) | 0.63968437 |
144 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 0.60698228 |
145 | Dicarboxylic aciduria (HP:0003215) | 0.60698228 |
146 | Papilledema (HP:0001085) | 0.60468854 |
147 | Focal motor seizures (HP:0011153) | 0.58170812 |
148 | Metabolic alkalosis (HP:0200114) | 0.56635669 |
149 | Large eyes (HP:0001090) | 0.55486538 |
150 | Fatigue (HP:0012378) | 0.55129106 |
151 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 0.55040556 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MET | 5.31105426 |
2 | FLT3 | 4.66918207 |
3 | EEF2K | 4.19244385 |
4 | BMPR1B | 4.04383992 |
5 | MAP3K13 | 3.81758895 |
6 | MAP3K10 | 3.59788199 |
7 | MAP4K1 | 3.12398986 |
8 | KIT | 2.94177748 |
9 | GRK6 | 2.45118513 |
10 | PIK3CG | 2.42290307 |
11 | ERN1 | 2.40664398 |
12 | TXK | 2.38620532 |
13 | RPS6KB2 | 2.38451487 |
14 | MST4 | 2.35742344 |
15 | CDC7 | 2.34949536 |
16 | CDK8 | 2.27461931 |
17 | CSF1R | 2.26215799 |
18 | PKN2 | 2.13978800 |
19 | SYK | 2.08781147 |
20 | VRK2 | 2.03462973 |
21 | NME2 | 1.83659839 |
22 | ZAP70 | 1.83421253 |
23 | MAP3K14 | 1.83377554 |
24 | YES1 | 1.74151967 |
25 | NLK | 1.73978566 |
26 | ITK | 1.69315642 |
27 | BTK | 1.67242223 |
28 | NEK2 | 1.61874913 |
29 | TEC | 1.61329975 |
30 | RPS6KB1 | 1.56073195 |
31 | FRK | 1.52724657 |
32 | LRRK2 | 1.51680414 |
33 | STK10 | 1.48572456 |
34 | RIPK4 | 1.47673689 |
35 | MAP3K7 | 1.44077872 |
36 | ADRBK2 | 1.44019055 |
37 | TLK1 | 1.43052681 |
38 | MAPK4 | 1.34181347 |
39 | FGFR2 | 1.32724744 |
40 | MAPK11 | 1.29395498 |
41 | WEE1 | 1.28186080 |
42 | TSSK6 | 1.27203106 |
43 | SCYL2 | 1.25563084 |
44 | KDR | 1.22341800 |
45 | MAPKAPK3 | 1.20224691 |
46 | MAPK7 | 1.18710243 |
47 | TYK2 | 1.18566313 |
48 | MAPK12 | 1.13432284 |
49 | LCK | 1.13336829 |
50 | EIF2AK3 | 1.13198398 |
51 | PLK2 | 1.11576520 |
52 | STK4 | 1.11574822 |
53 | TESK2 | 1.09580474 |
54 | TNIK | 1.08988097 |
55 | PIM1 | 1.08326775 |
56 | MAPK13 | 1.06903846 |
57 | PRKCH | 1.05502278 |
58 | FGFR3 | 1.05039920 |
59 | SIK2 | 1.04460205 |
60 | CLK1 | 1.02602787 |
61 | HIPK2 | 0.99119225 |
62 | CDK4 | 0.98904264 |
63 | FGFR4 | 0.97737269 |
64 | BCKDK | 0.93306143 |
65 | TBK1 | 0.93085909 |
66 | PASK | 0.91738868 |
67 | HCK | 0.91733664 |
68 | PDGFRB | 0.89188879 |
69 | CSK | 0.87372415 |
70 | FES | 0.87298586 |
71 | SRPK1 | 0.86316169 |
72 | CDK6 | 0.85887540 |
73 | PTK6 | 0.85258720 |
74 | ATR | 0.84901009 |
75 | BUB1 | 0.84063124 |
76 | DYRK3 | 0.83552223 |
77 | CDK12 | 0.83162872 |
78 | PRKD2 | 0.81766642 |
79 | DAPK1 | 0.79468624 |
80 | MAP3K11 | 0.79034768 |
81 | TGFBR1 | 0.74217437 |
82 | CCNB1 | 0.73772828 |
83 | TGFBR2 | 0.72679129 |
84 | MAPKAPK5 | 0.68938445 |
85 | ZAK | 0.64778915 |
86 | ACVR1B | 0.63223798 |
87 | PIM2 | 0.61382426 |
88 | MARK2 | 0.61045367 |
89 | JAK3 | 0.60194600 |
90 | CDK9 | 0.60039376 |
91 | LYN | 0.59700029 |
92 | CAMK1 | 0.59205270 |
93 | TYRO3 | 0.58709048 |
94 | BMPR2 | 0.57203918 |
95 | DYRK1A | 0.56433516 |
96 | TRPM7 | 0.55323965 |
97 | DYRK1B | 0.54828809 |
98 | PINK1 | 0.53554644 |
99 | TAOK3 | 0.53455644 |
100 | VRK1 | 0.53432431 |
101 | TRIB3 | 0.52928213 |
102 | EGFR | 0.52768991 |
103 | STK11 | 0.51591325 |
104 | PRKCI | 0.50400845 |
105 | ARAF | 0.50127993 |
106 | BRD4 | 0.49868130 |
107 | UHMK1 | 0.49821014 |
108 | IKBKE | 0.49682528 |
109 | STK39 | 0.48803838 |
110 | MARK3 | 0.47884288 |
111 | PRKCQ | 0.47833747 |
112 | MAP3K12 | 0.47428069 |
113 | NUAK1 | 0.47094627 |
114 | MAP3K8 | 0.46404266 |
115 | CDK3 | 0.45602093 |
116 | PAK2 | 0.44406835 |
117 | WNK4 | 0.43117189 |
118 | RPS6KA2 | 0.41197631 |
119 | CHEK1 | 0.40282527 |
120 | JAK2 | 0.40072842 |
121 | AURKB | 0.39860931 |
122 | STK16 | 0.39318066 |
123 | MAPK3 | 0.38326516 |
124 | CDK7 | 0.36542599 |
125 | IKBKB | 0.36446609 |
126 | CSNK1A1L | 0.36270594 |
127 | ERBB2 | 0.35844933 |
128 | MKNK1 | 0.35406732 |
129 | RPS6KA6 | 0.34761626 |
130 | INSRR | 0.34521437 |
131 | RPS6KA4 | 0.34382923 |
132 | TAF1 | 0.34276266 |
133 | RAF1 | 0.34066335 |
134 | EPHB1 | 0.33792552 |
135 | CDK19 | 0.33664329 |
136 | ATM | 0.32024211 |
137 | CDK2 | 0.31799616 |
138 | PRKDC | 0.30703912 |
139 | RPS6KC1 | 0.30330136 |
140 | RPS6KL1 | 0.30330136 |
141 | NTRK2 | 0.29967734 |
142 | CSNK1D | 0.29828391 |
143 | PRKCE | 0.29425568 |
144 | DYRK2 | 0.29072762 |
145 | MKNK2 | 0.27712951 |
146 | WNK1 | 0.26204712 |
147 | ABL1 | 0.25247831 |
148 | MAP2K2 | 0.22789305 |
149 | IGF1R | 0.22308615 |
150 | INSR | 0.21931754 |
151 | GRK1 | 0.20987674 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.58286776 |
2 | DNA replication_Homo sapiens_hsa03030 | 4.29959507 |
3 | * Non-homologous end-joining_Homo sapiens_hsa03450 | 3.57291041 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.28786356 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 3.13687164 |
6 | Ribosome_Homo sapiens_hsa03010 | 3.12423199 |
7 | Asthma_Homo sapiens_hsa05310 | 2.92939070 |
8 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.79216340 |
9 | Base excision repair_Homo sapiens_hsa03410 | 2.65818995 |
10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.61382746 |
11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.42246649 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.32799648 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31781312 |
14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.02699232 |
15 | Spliceosome_Homo sapiens_hsa03040 | 1.93343659 |
16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.88455017 |
17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.87717625 |
18 | Measles_Homo sapiens_hsa05162 | 1.81004308 |
19 | Cell cycle_Homo sapiens_hsa04110 | 1.77636017 |
20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74364329 |
21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69565841 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66998225 |
23 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66705566 |
24 | Homologous recombination_Homo sapiens_hsa03440 | 1.60130722 |
25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.56617480 |
26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47618243 |
27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34626338 |
28 | Allograft rejection_Homo sapiens_hsa05330 | 1.30502918 |
29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.30480636 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29881243 |
31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25212614 |
32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25176404 |
33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25092689 |
34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23645880 |
35 | Colorectal cancer_Homo sapiens_hsa05210 | 1.20139827 |
36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16970107 |
37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12465052 |
38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11708345 |
39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11503054 |
40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10222811 |
41 | Alcoholism_Homo sapiens_hsa05034 | 1.06081053 |
42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05429217 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03024625 |
44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02359141 |
45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01260326 |
46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01060488 |
47 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99918249 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 0.96207126 |
49 | RNA degradation_Homo sapiens_hsa03018 | 0.95399394 |
50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93362409 |
51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86830089 |
52 | Legionellosis_Homo sapiens_hsa05134 | 0.86215153 |
53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85742865 |
54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84666535 |
55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83273244 |
56 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79211213 |
57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78150476 |
58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76716091 |
59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76576046 |
60 | RNA transport_Homo sapiens_hsa03013 | 0.76331122 |
61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72050267 |
62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71250175 |
63 | Influenza A_Homo sapiens_hsa05164 | 0.70849306 |
64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70768008 |
65 | Phototransduction_Homo sapiens_hsa04744 | 0.68606905 |
66 | Peroxisome_Homo sapiens_hsa04146 | 0.68425017 |
67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67284789 |
68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66712866 |
69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64335315 |
70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63549050 |
71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63243322 |
72 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.62672891 |
73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59686453 |
74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58871303 |
75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58508306 |
76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58487999 |
77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57962989 |
78 | Prostate cancer_Homo sapiens_hsa05215 | 0.56641662 |
79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56076041 |
80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55811179 |
81 | Lysine degradation_Homo sapiens_hsa00310 | 0.55224401 |
82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54870938 |
83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54506163 |
84 | Purine metabolism_Homo sapiens_hsa00230 | 0.54441556 |
85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52769841 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52737184 |
87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50731092 |
88 | Platelet activation_Homo sapiens_hsa04611 | 0.50266095 |
89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49032834 |
90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48730656 |
91 | Apoptosis_Homo sapiens_hsa04210 | 0.45979258 |
92 | Pertussis_Homo sapiens_hsa05133 | 0.45577841 |
93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45352846 |
94 | Shigellosis_Homo sapiens_hsa05131 | 0.43523461 |
95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40397548 |
96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37594414 |
97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36739232 |
98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36606650 |
99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35688387 |
100 | Malaria_Homo sapiens_hsa05144 | 0.34721397 |
101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34586773 |
102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32883924 |
103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32474553 |
104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32451831 |
105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31495174 |
106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31293088 |
107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31162415 |
108 | Proteasome_Homo sapiens_hsa03050 | 0.30595156 |
109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.28117573 |
110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26508182 |
111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25859340 |
112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25033828 |
113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24690400 |
114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24647291 |
115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24645276 |
116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24336923 |
117 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.24214737 |
118 | RNA polymerase_Homo sapiens_hsa03020 | 0.24098364 |
119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23895974 |
120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.22818238 |
121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.20867397 |
122 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.20856985 |
123 | Hepatitis C_Homo sapiens_hsa05160 | 0.20100752 |
124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.20045939 |
125 | Glioma_Homo sapiens_hsa05214 | 0.19193642 |
126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.18854750 |
127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.18476000 |
128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.18457739 |
129 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17385494 |
130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.17326046 |
131 | ABC transporters_Homo sapiens_hsa02010 | 0.17152124 |
132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.16676428 |
133 | Tuberculosis_Homo sapiens_hsa05152 | 0.16368943 |
134 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.15994408 |
135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15486989 |
136 | Insulin resistance_Homo sapiens_hsa04931 | 0.10361655 |
137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.09540891 |
138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.09093476 |
139 | Melanoma_Homo sapiens_hsa05218 | 0.08202601 |